Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kort, Anita"'
Publikováno v:
In Journal of Chromatography B 15 June 2016 1023-1024:24-29
Autor:
Kort, Anita, Sparidans, Rolf, Wagenaar, Els, Beijnen, Jacob, Schinkel, Alfred H., Sub Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Pharmacological Research, 102, 200. Academic Press Inc.
We aimed to clarify the roles of the multidrug transporters ABCB1 and ABCG2 in oral availability and brain accumulation of ceritinib, an oral anaplastic lymphoma kinase (ALK) inhibitor used to treat metastatic non-small cell lung cancer (NSCLC) after
Autor:
Kort, Anita, van Hoppe, Stéphanie, Sparidans, Rolf W, Wagenaar, Els, Beijnen, Jos H, Schinkel, Alfred H
Ponatinib is an oral BCR-ABL1 inhibitor for treatment of advanced leukemic diseases that carry the Philadelphia chromosome, specifically containing the T315I mutation yielding resistance to previously approved BCR-ABL1 inhibitors. Using in vitro tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______101::dfdce4590de593ed63a1447ad7b6b5a9
https://dspace.library.uu.nl/handle/1874/356206
https://dspace.library.uu.nl/handle/1874/356206
Autor:
Kort, Anita, Durmus, Selvi, Sparidans, Rolf W., Wagenaar, Els, Beijnen, Jos H., Schinkel, Alfred H.
Purpose: Regorafenib is a novel multikinase inhibitor, currently approved for the treatment of metastasized colorectal cancer and advanced gastrointestinal stromal tumors. We investigated whether regorafenib is a substrate for the multidrug efflux tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______101::adec5979058653ab3bb3f5e398719381
https://dspace.library.uu.nl/handle/1874/327271
https://dspace.library.uu.nl/handle/1874/327271
Autor:
Kort, Anita, van Hoppe, Stéphanie, Sparidans, Rolf W., Wagenaar, Els, Beijnen, Jos H., Schinkel, Alfred H.
Publikováno v:
Molecular Pharmaceutics; 20240101, Issue: Preprints
Autor:
Kort, Anita, Durmus, Selvi, Sparidans, Rolf W., Wagenaar, Els, Beijnen, Jos H., Schinkel, Alfred H., Pharmacoepidemiology and Clinical Pharmacology, Sub Medicinal Chemistry & Chemical biol., Sub Clinical Pharmacology
Publikováno v:
Pharmaceutical Research, 32(7), 2205. Springer New York LLC
Regorafenib is a novel multikinase inhibitor, currently approved for the treatment of metastasized colorectal cancer and advanced gastrointestinal stromal tumors. We investigated whether regorafenib is a substrate for the multidrug efflux transporter
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kort A; Division of Molecular Oncology, The Netherlands Cancer Institute , Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital , Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., van Hoppe S; Division of Molecular Oncology, The Netherlands Cancer Institute , Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Sparidans RW; Division of Pharmacoepidemiology & Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University , Universiteitsweg 99, 3584 CG Utrecht, The Netherlands., Wagenaar E; Division of Molecular Oncology, The Netherlands Cancer Institute , Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Beijnen JH; Division of Pharmacoepidemiology & Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University , Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital , Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; Department of Clinical Pharmacology, The Netherlands Cancer Institute , Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Schinkel AH; Division of Molecular Oncology, The Netherlands Cancer Institute , Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2017 Oct 02; Vol. 14 (10), pp. 3258-3268. Date of Electronic Publication: 2017 Sep 19.
Autor:
Kort A; Division of Molecular Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Durmus S, Sparidans RW, Wagenaar E, Beijnen JH, Schinkel AH
Publikováno v:
Pharmaceutical research [Pharm Res] 2015 Jul; Vol. 32 (7), pp. 2205-16. Date of Electronic Publication: 2015 Jan 08.